Answers are grounded in this paper and cite their sources.
The therapeutic performance of Ag+-based dressings is closely linked to Ag+ release, with excessive release causing cytotoxicity and insufficient release limiting antibacterial efficacy. Here, we developed a chitosan hydrogel embedding Ce-Zr oxide (CZ) nanozymes decorated with tannic acid-mediated silver (CZTAg) for microenvironment-responsive diabetic wound therapy. Ag+ was immobilized as a thin layer on CZ nanoparticles, enabling pH-dependent release: higher under weakly alkaline conditions and lower under acidic conditions, corresponding to infected and healing wound stages. After 48 h, TA-Ag released about 90 and 72% of Ag+ at pH 7.4 and 5.0, whereas CZTAg released about 71 and 61%, demonstrating the release-moderating effect of CZ. XPS confirmed Ag0/Ag+ coexistence, supporting a biphasic release mechanism. In addition, CZ nanozymes scavenged reactive oxygen species via Ce3+/Ce4+ redox cycling. The CZTAg hydrogel effectively inhibited bacterial growth, reduced oxidative stress, and accelerated wound closure in a diabetic mouse model. This work provides a rational platform for integrating nanozyme-mediated redox activity with controlled, stage-adaptive silver delivery, balancing antibacterial efficacy and cytocompatibility.
No takes yet. Share an insight, caveat, or question.
Ouyang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: